Johnson & Johnson uses the prospect of jail time to market a schizophrenia drug

Quick Read

This was the first time a person was executed using a new three-drug protocol that included the drug etomidate. It replaced the sedative midazolam, which has been used in multiple prolonged or seemingly painful executions in the past, and which pharmaceutical companies have refused to sell for use in executions, leading to shortages

Quick Read

Johnson & Johnson has appointed Arthur Caplan, a nationally known bioethicist, to create a panel that will make decisions about patients’ requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they are approved

Quick Read